Anticorps Monoclonal anti-STRO-1

STRO-1 Monoclonal Antibody for FC

Hôte / Isotype

Mouse / IgM, lambda

Réactivité testée

Humain

Applications

FC

Conjugaison

Non conjugué

Publications(1)

CloneNo.

STRO-1

N° de cat : 65184-1-Ig

Synonymes

STRO-1

---

Galerie de données de validation

• 

  FC experiment of human blood using 65184-1-Ig

  1X10^6 lysed human blood cells were surface stained with 0.2 ug Anti-Human STRO-1 (65184-1-Ig, Clone:STRO-1) and AlexaFluor-Goat anti-Mouse IgG at dilution 1:1000. Cells were not fixed. CD45 dim, CD34 positive cells were gated.

• 

  FC experiment of human blood using 65184-1-Ig

  1X10^6 lysed human blood cells were surface stained with 0.2 ug Anti-Human STRO-1 (65184-1-Ig, Clone:STRO-1) and AlexaFluor-Goat anti-Mouse IgG at dilution 1:1000. Cells were not fixed. CD45 dim, CD34 positive cells were gated.

---

Applications testées

• Résultats positifs en cytométrie: sang humain,

Dilution recommandée

Application	Dilution
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Applications publiées

• FC: See 1 publications below

Informations sur le produit

65184-1-Ig cible STRO-1 dans les applications de FC et montre une réactivité avec des échantillons Humain

• Réactivité: Humain
• Réactivité citée: Humain
• Hôte / Isotype: Mouse / IgM, lambda
• Clonalité: Monoclonal
• Type: Anticorps
• Immunogène: Cellules médullaires humaines CD34 positives
• Nom complet: STRO-1
• Conjugaison: Non conjugué
• Forme: Liquide
• Méthode de purification: Purifié par précipitation et chromatographie
• Tampon de stockage: PBS with 0.09% sodium azide
• Conditions de stockage: Store at 2-8°C. Stable for one year after shipment.

Publications

Species	Application	Title
human	FC	Biochim Biophys Acta Mol Cell Res; Senolytic elimination of senescent cells improved periodontal ligament stem cell-based bone regeneration partially through inhibiting YAP; Authors - Linglu Jia

{{ptg:RelatedPrimaryAntibodies}}